Gambaran Karakteristik dan Komorbiditas Pasien PPOK Rawat Inap di Rsud Al-Ihsan Bandung 2016

Tiara Chairunnissa, Cice Tresnasari, Eka Hendryanny

Abstract


Beberapa faktor risiko yang mempengaruhi perjalanan penyakit PPOK adalah merokok, usia, serta jenis kelamin. Pasien PPOK memiliki komorbiditas yang mempengaruhi kualitas dan kelangsungan hidup secara signifikan. Penelitian ini dilakukan untuk mengetahui gambaran karakteristik dan komorbiditas pasien PPOK yang dirawat inap di RSUD Al-Ihsan tahun 2016. Penelitian ini menggunakan metode deskriptif dengan pendekatan retrospektif, dilakukan pada bulan Mei—Juli 2017 di RSUD Al-Ihsan Kabupaten Bandung menggunakan 92 rekam medis pasien PPOK yang dirawat inap pada tahun 2016. Variabel yang diidentifikasi meliputi usia, jenis kelamin, status merokok, dan komorbiditas. Pemilihan sampel data rekam medis menggunakan metode total sampling dan data diproses dengan Microsoft Excel 2016 dan disajikan dalam bentuk tabel. Hasil penelitian menunjukkan bahwa pasien PPOK memiliki karakteristik jenis kelamin pria (76,09%), berusia ≥ 65 tahun (70,66%), dengan proporsi pasien yang merokok sebesar 18,48%. Sebagian besar pasien PPOK memiliki komorbiditas (75,28%) dan proporsi penyakit komorbid terbesar yaitu CHF (27,14%), diikuti CAD (15,71%) dan HHD (10,00%). Kesimpulan penelitian ini yaitu pasien PPOK yang dirawat inap di RSUD Al-Ihsan periode Januari—Desember 2016 sebagian besar adalah pria, berusia ≥ 65 tahun, dan tidak merokok. Sebagian besar pasien memiliki komorbiditas, dengan CHF, CAD dan HHD sebagai komorbid yang paling sering.

Keywords


Karakteristik, Komorbiditas, PPOK

References


Global Initiative For Obstructive Lung Disease. Global Strategy For The Diagnosis, Management, And Prevention of Chronic Obstructive Pulmonary Disease (Updated 2016). 2016.

Vos T, Allen C, Arora M, Barber RM, Bhutta ZA, Brown A, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet [serial on the Internet]. 2016 Okt [diunduh 31 Desember 2016];388(10053):1545–602. Tersedia dari : http://www.thelancet.com/article/S0140673616316786/fulltext

Pusat Data dan Informasi Kemenkes RI. Gambaran Penyakit Tidak Menular Di Rumah Sakit Di Indonesia Tahun 2009 dan 2010. Bul Jendela Data dan Inf Kesehat Penyakit Tidak Menular. 2012;2:1–13.

Huang R, Wei Y, J. Hung R, Liu G, Ruyang Zhang LS, Al E. Associated Links Among Smoking, Chronic Obstructive Pulmonary Disease, and Small Cell Lung Cancer: A Pooled Analysis in the International Lung Cancer Consortium. EBioMedicine. 2015;2(11):1578–9.

Mannino DM, Buist AS. Global burden of COPD: risk factors, prevalence, and future trends. Lancet. 2007;370(9589):765–73.

Hwang S-L, Lin Y-C, Guo S-E, Chi M-C, Chou C-T, Lin C-M. Prevalence of Chronic Obstructive Pulmonary Disease in Southwestern Taiwan: A Population-Based Study. Int J Respir Pulm Med. 2016;3(3).

Aini DQ, Suryadinata H, Herdiningrat RBS. Comorbidity among Hospitalized Patients with Chronic Obstructive Pulmonary Disease in a Teaching Hospital, West Java Indonesia. Althea Med J. 2015;2(4):485–91.

Nathalia C. Karakteristik Penderita Penyakit Paru Obstruktif Kronik Di Rumah Sakit Immanuel Bandung Tahun 2012. Universitas Kristen Maranatha; 2015.

Blanc P, Menezes A, Plana E, Mannino D, Hallal P, Toren K, et al. Occupational exposures and COPD: an ecological analysis of international data. Eur Respir J. 2009;33(2):298–304.

Salvi S. Tobacco Smoking and Environmental Risk Factors for Chronic Obstructive Pulmonary Disease. Clin Chest Med. 2014;35(1):17–27.

Lim S, Chi-Leung Lam D, Muttalif AR, Yunus F, Wongtim S. Impact of Chronic Obstructive Pulmonary Disease (COPD) in The Asia-Pacific Region: The EPIC Asia Population-Based Survey. Asia Pac Fam Med. 2015;14(4).

Nguyen Viet N, Yunus F, Nguyen Thi Phuong A, Dao Bich V, Damayanti T. The prevalence and patient characteristics of chronic obstructive pulmonary disease in non-smokers in Vietnam and Indonesia: An observational survey. Respirology. 2015;20(4):602–11.

Zhou Y, Wang C, Yao W, Chen P, Kang J, Huang S. COPD in Chinese nonsmokers. Eur Respir J. 2009;33(3):509–518.

Ito K, Barnes P. COPD as a Disease of Accelerated Lung Aging. Chest. 2009;135(1):173–80.

Fishman AP, Elias JA, Fishman JA, Grippi MA, Senior RM, Pack AI. Fishman’s Pulmonary Diseases and Disorders. 5th ed. New York: McGraw-Hill; 2015.

Liu Y, Pleasants RA, Croft JB, Wheaton AG, Heidari K. Smoking duration, respiratory symptoms, and COPD in adults aged ≥45 years with a smoking history. Int J Chronic Obstr Respir Dis. 2015;10:1409–1416.

Hagstad S, Bjerg A, Ekerljung L, Backman H, Lindberg A. Passive smoking exposure is associated with increased risk of COPD in never smokers. Chest. 2014;145(6):1298–304.

Jordan RE, Cheng KK, Miller MR, Adab P. Passive smoking and chronic obstructive pulmonary disease: cross sectional analysis of data from the Health Survey for England. BMJ Open. 2011;1(2).

Kaszuba E, Odeberg H, Råstam L, Halling A. Heart failure and levels of other comorbidities in patients with chronic obstructive pulmonary disease in a Swedish population: a register-based study. BMC Res Notes. 2016;9(215).

Drazner M. The Progression of Hypertensive Heart Disease. Circulation. 2011;123:327–34.

Güder G, Rutten FH. Comorbidity of Heart Failure and Chronic Obstructive Pulmonary Disease: More than Coincidence. Curr Heart Fail Rep. 2014;11(3):337–46.

Barnes P, Celli B. Systemic manifestations and comorbidities of COPD. Eur Respir J. 2009;33(5):1165–85.

Velagaleti R, Vasan RS. Heart Failure in the 21st Century: Is it a Coronary Artery Disease Problem or Hypertension Problem? Cardiol Clin. 2007;25(4):487–v.

Inghammar M, Ekbom A, Engström G, Ljungberg B, Romanus V. COPD and the Risk of Tuberculosis - A Population-Based Cohort Study. PLoS One. 2010;5(4):e10138.

Sahal YP, Afghani A, Nilapsari R. The Relationship of Lymphocyte Cell Count with Age and Nutritional Status in Tuberculosis Patients. Glob Med Heal Commun. 2014;2(2):73–8.

Lin S, Ji B, Shih Y, Chen C, Chan P, Chang Y, et al. Comorbid pulmonary disease and risk of community-acquired pneumonia in COPD patients. Int J Tuberc Lung Dis. 2013;17(12):1638–44.




Flag Counter